2.56 (-%)
As of Nov 22, 2024
Source:
We are a drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic potential of proteins. We built our Integrated Drug Creation Platform to identify novel drug targets, discover optimal biotherapeutic candidates, and generate the cell lines to manufacture them in a single efficient process. We believe our approach delivers disruptive efficiency, but more importantly enables our partners to create novel and human/AI-designed new-to-nature biologics (next-generation biologics).
Country | United States |
Headquarters | vancouver, washington |
Phone Number | (360) 949-1041 |
Industry | |
CEO | Sean Mcclain |
Website | https://www.absci.com |